Marsh Cinquefoil

Marsh cinquefoil roots contain the bioactive pectin comaruman alongside tannins (≥3%), quercetin (≥8.5%), and kaempferol (≥6.1%), with comaruman suppressing neutrophil infiltration by reducing myeloperoxidase activity and stimulating colonic mucus production. In an acetic acid-induced mouse colitis model, oral comaruman pretreatment significantly reduced colonic tissue damage and myeloperoxidase activity within 24 hours compared to untreated colitis controls, representing the primary preclinical evidence for its anti-inflammatory utility.

Origin & History

Comarum palustre is a semi-aquatic perennial herb native to wetlands, bogs, marshes, and fens across northern Europe, Russia, Siberia, and parts of North America and Alaska, thriving in cold, waterlogged, acidic soils. It grows in dense mats along riverbanks and peat bogs at low to subalpine elevations, often alongside sphagnum moss and sedges. The plant has been harvested from wild stands rather than cultivated commercially, with roots collected in autumn and aerial parts gathered during flowering in traditional Russian and Gaelic folk medicine.

Historical & Cultural Context

Comarum palustre has been employed across geographically and culturally distinct folk medicine traditions spanning Gaelic Scotland and Ireland, Russian and Siberian herbalism, Bulgarian folk medicine, and Alaskan Indigenous healing practices, reflecting its wide wetland distribution across the northern hemisphere. In Russian and Siberian traditions, the root was the most prized part, prepared as decoctions for dysentery, intestinal cramps, and musculoskeletal pain, and its formal recognition in the Russian State Pharmacopeia in 2008 represents one of the few instances where a traditional Slavic medicinal plant received official pharmaceutical status in the modern era. Gaelic herbalists valued its astringent tannin content for wound healing and controlling internal hemorrhage, consistent with the broader European tradition of using tannin-rich plants from the Rosaceae family as hemostatics and intestinal astringents. Alaskan Indigenous communities reportedly used aerial parts as teas for fevers and general internal pain, demonstrating an independently developed convergent use pattern that aligns with the anti-inflammatory and antimicrobial properties now being characterized in preclinical research.

Health Benefits

- **Gastrointestinal Mucosal Protection**: Comaruman, the root-derived pectin, stimulates mucus production in both healthy and inflamed colonic tissue, physically reinforcing the mucosal barrier against irritants and pathogens.
- **Anti-Inflammatory Activity**: Root extracts reduce myeloperoxidase activity in colitis models, indicating suppression of neutrophil-driven oxidative inflammation at sites of tissue injury.
- **Astringent and Antidiarrheal Effects**: High tannin content (≥3% in standardized roots) precipitates mucosal proteins, tightening intestinal tissue and historically justifying use in dysentery and stomach cramps in Gaelic and Russian folk medicine.
- **Antimicrobial Properties**: Water and water-ethanol extracts from both roots and aerial parts exhibit antimicrobial activity, attributed to the combined action of quercetin-like flavonoids, polyphenols, and monoterpenes including pinene and citronellal.
- **Antioxidant Defense**: Phenolic compounds including quercetin (≥8.5%) and kaempferol (≥6.1%) contribute electron-donating antioxidant activity, scavenging reactive oxygen species implicated in chronic inflammation and cellular damage.
- **Stress-Protective Effects**: Extracts from roots and aerial parts have demonstrated adaptogenic-type stress-protective effects in Russian preclinical pharmacological literature, though precise mechanisms and models remain incompletely characterized.
- **Potential Antitumor Activity**: Isolated phenolic fractions and polysaccharide extracts have shown preliminary antitumor properties in preclinical screens, consistent with the broader cytotoxic and antiproliferative activity observed in tannin- and flavonoid-rich plant extracts.

How It Works

Comaruman, a pectin-type polysaccharide isolated from Comarum palustre roots, exerts anti-inflammatory effects by reducing vascular permeability and decreasing adhesion of peritoneal neutrophils and macrophages to endothelial surfaces, thereby limiting inflammatory cell trafficking to sites of tissue injury. In colitis models, comaruman pretreatment reduces colonic myeloperoxidase activity, an enzyme released by activated neutrophils that generates hypochlorous acid and drives oxidative tissue destruction, indicating direct suppression of neutrophil-mediated oxidative stress. Quercetin and kaempferol, present at pharmacopoeial-grade concentrations, are known inhibitors of pro-inflammatory enzymes including cyclooxygenase and lipoxygenase, and modulate NF-κB transcriptional activity, though pathway-specific data for Comarum palustre extracts have not been directly demonstrated in published molecular studies. Tannins contribute through protein-precipitating astringency that reduces mucosal permeability and inhibits microbial adhesion, complementing the polysaccharide and flavonoid fractions through distinct, non-overlapping mechanisms.

Scientific Research

The available evidence base for Comarum palustre is limited exclusively to in vitro antimicrobial assays, phytochemical isolation studies, and a small number of preclinical in vivo experiments, with no published human clinical trials identified as of the current literature search. The most substantive mechanistic study involves an acetic acid-induced murine colitis model in which oral comaruman pretreatment reduced colonic myeloperoxidase activity and stimulated mucus production compared to untreated colitis controls, but critical details including sample sizes, dosing regimens, and statistical effect sizes were not reported in available secondary sources. Phytochemical investigations have isolated at least seven phenolic compounds from aerial parts, five of which were newly identified structural characterizations, confirming chemical diversity but not bioactivity in humans. The plant's roots have been registered in the Russian pharmacopeia since 2008 with defined quality standards for tannins, catechins, quercetin, and kaempferol, representing regulatory validation of traditional use rather than efficacy evidence from controlled trials.

Clinical Summary

No randomized controlled trials, observational cohort studies, or systematic reviews involving human subjects have been conducted on Comarum palustre or its isolated constituents including comaruman. The entire clinical evidence base rests on a preclinical murine colitis model demonstrating reduced tissue damage, lower myeloperoxidase activity, and enhanced mucus production following oral comaruman administration, with outcomes measured at 24 hours post-induction. Effect sizes, confidence intervals, and replication across independent laboratories are not documented in accessible literature, substantially limiting confidence in translating these findings to human therapeutic applications. Russian pharmacopoeial registration of the root drug since 2008 reflects historical consensus on traditional use and phytochemical quality standards rather than efficacy data from prospective clinical investigation.

Nutritional Profile

Comarum palustre roots and aerial parts are not consumed as a food source and thus lack conventional macronutrient or micronutrient nutritional data; their pharmacological profile is defined by secondary metabolite concentrations rather than nutritional composition. The root drug is standardized phytochemically to contain tannins ≥3% (primarily hydrolyzable and condensed tannin fractions), catechins ≥0.1%, total extractives ≥15%, quercetin ≥8.5%, and kaempferol ≥6.1% by dry weight per Russian pharmacopoeial specifications. Volatile fraction analysis has identified monoterpenes including α-pinene, terpineol, and citronellal in both roots and aerial parts, contributing to the plant's antimicrobial aromatic profile. The polysaccharide fraction includes comaruman, a pectin-type polymer whose precise monosaccharide composition and molecular weight have not been fully characterized in publicly available literature, limiting bioavailability modeling; pectins generally exhibit low systemic absorption and exert primary effects within the gastrointestinal lumen.

Preparation & Dosage

- **Root Decoction (Traditional Russian/Folk)**: 10–15 g of dried, chopped roots simmered in 200–300 mL water for 20–30 minutes, strained and consumed 2–3 times daily for gastrointestinal complaints including dysentery and stomach cramps; no clinically validated dose established.
- **Dried Leaf Tea**: Dried aerial parts prepared as hot infusion (5–10 g per 250 mL boiling water, steeped 10–15 minutes) historically used in Alaskan Indigenous and Gaelic traditions for fevers and internal pains.
- **Water-Ethanol Extract (Research Grade)**: 40–70% ethanol extracts of roots and aerial parts used in preclinical antimicrobial and anti-inflammatory studies; no standardized commercial dose formalized outside Russian pharmacopoeial quality specifications.
- **Pharmacopoeial Root Drug (Russia)**: Standardized to tannins ≥3%, catechins ≥0.1%, extractives ≥15%, quercetin ≥8.5%, kaempferol ≥6.1%; these are quality benchmarks, not dosing thresholds for clinical use.
- **Dietary Supplement Blend**: One formulation combined marsh cinquefoil extract with burdock root, fish cartilage, and cephalopod-derived compounds; specific doses per component and validated efficacy data are not published.
- **Timing Note**: No pharmacokinetic data on optimal timing relative to meals or other medications exists; traditional preparations were typically consumed with or after meals for gastrointestinal conditions.

Synergy & Pairings

In one documented formulation, marsh cinquefoil extract was combined with burdock root (Arctium lappa), fish cartilage-derived glycosaminoglycans, and cephalopod-derived compounds, theoretically pairing Comarum's anti-inflammatory phenolics and comaruman with burdock's inulin-type prebiotics and marine-derived collagen precursors to support gastrointestinal and connective tissue health through complementary mechanisms. The flavonoid quercetin present at high concentrations in Comarum palustre roots is known to synergize with vitamin C, which enhances quercetin bioavailability by regenerating oxidized quercetin and extending its antioxidant action, though this pairing has not been specifically tested with Comarum extracts. Traditional Gaelic and Russian herbalism frequently combined astringent tannin-rich roots with demulcent mucilaginous plants to balance tissue-tightening effects with soothing mucosal coating, a rationale consistent with combining marsh cinquefoil with marshmallow root (Althaea officinalis) for gastrointestinal applications.

Safety & Interactions

No formal toxicological studies, maximum tolerated dose determinations, or human safety trials have been published for Comarum palustre extracts or comaruman, and the current evidence base is insufficient to establish definitive safety parameters for supplemental use. The high tannin content (≥3%) common to root preparations may inhibit intestinal absorption of iron, zinc, and certain pharmaceutical compounds including tetracycline antibiotics and some alkaloid-based medications if consumed simultaneously, a concern extrapolated from the established pharmacology of tannins rather than Comarum-specific interaction data. No explicit contraindications, adverse events, or drug interactions have been reported in available literature, and related plant extracts screened in antiviral assays showed low cytotoxicity (CC50 >1500 µg/mL in related species), suggesting general cellular tolerability at low concentrations. Safety during pregnancy and lactation has not been evaluated; given the absence of human safety data and the presence of biologically active tannins and flavonoids at significant concentrations, use during pregnancy, lactation, or alongside medications with narrow therapeutic indices is not advisable without medical supervision.